Publication | Closed Access

Dose-adjusted preemptive therapy for cytomegalovirus disease based on real-time polymerase chain reaction after allogeneic hematopoietic stem cell transplantation

Cell TherapyTransplantationCytomegalovirus DiseaseStem Cell TransplantationImmunologyHematologyVirologyDose-adjusted Preemptive TherapyImmunotherapyMedicineCell Transplantation